162 related articles for article (PubMed ID: 10822221)
21. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
[TBL] [Abstract][Full Text] [Related]
22. Importance of low serum DNase I activity and polyspecific anti-neutrophil cytoplasmic antibodies in propylthiouracil-induced lupus-like syndrome.
Gajic-Veljic M; Bonaci-Nikolic B; Lekic B; Skiljevic D; Ciric J; Zoric S; Stojimirovic B; Nikolic M
Rheumatology (Oxford); 2015 Nov; 54(11):2061-70. PubMed ID: 26163691
[TBL] [Abstract][Full Text] [Related]
23. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
[TBL] [Abstract][Full Text] [Related]
24. Antineutrophil Cytoplasmic Antibody-Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy: How Significant Is the Clinical Problem?
Balavoine AS; Glinoer D; Dubucquoi S; Wémeau JL
Thyroid; 2015 Dec; 25(12):1273-81. PubMed ID: 26414658
[TBL] [Abstract][Full Text] [Related]
25. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
26. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
27. [Pyoderma gangrenosum associated with anti-proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) induced by propylthiouracil].
Coster A; Dargent JL; de Visscher N; Levecque P; Roquet-Gravy PP
Ann Dermatol Venereol; 2017 May; 144(5):368-373. PubMed ID: 28291538
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
[TBL] [Abstract][Full Text] [Related]
29. Propylthiouracil-induced antineutrophil cytoplasm antibody-positive anaphylactoid purpura-like vasculitis--a case report.
Wang LH; Tsai MJ; Tsai WY; Lee JS; Chiang BL
J Formos Med Assoc; 2000 Aug; 99(8):642-5. PubMed ID: 10969508
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
[TBL] [Abstract][Full Text] [Related]
31. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil.
Winters MJ; Hurley RM; Lirenman DS
Pediatr Nephrol; 2002 Apr; 17(4):257-60. PubMed ID: 11956877
[TBL] [Abstract][Full Text] [Related]
32. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies.
Kudoh Y; Kuroda S; Shimamoto K; Iimura O
Clin Nephrol; 1997 Jul; 48(1):41-3. PubMed ID: 9247777
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
Xu X; Zhao M; Zhang Y; Guo X; Wang H
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):404-7. PubMed ID: 12137604
[TBL] [Abstract][Full Text] [Related]
34. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
[TBL] [Abstract][Full Text] [Related]
35. Do antineutrophil cytoplasmic antibodies (ANCA) play a key role in neutrophilic dermatoses? A case of propylthiouracil-induced neutrophilic dermatosis with positive perinuclear ANCA.
Darné S; Natarajan S; Blasdale C
Clin Exp Dermatol; 2010 Jun; 35(4):406-8. PubMed ID: 19874374
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of antineutrophil cytoplasmic antibodies during treatment with benzylthiouracil.
Sghiri R; Ouertani M; Ben Hsine H; Slim I; Chaieb L; Ghedira I
Pathol Biol (Paris); 2009 Jul; 57(5):410-4. PubMed ID: 19201108
[TBL] [Abstract][Full Text] [Related]
37. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment.
Yazisiz V; Ongüt G; Terzioğlu E; Karayalçin U
Int J Clin Pract; 2010 Jan; 64(1):19-24. PubMed ID: 18284438
[TBL] [Abstract][Full Text] [Related]
38. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
Ye H; Gao Y; Guo XH; Zhao MH
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836
[TBL] [Abstract][Full Text] [Related]
39. Clinical features and outcomes in patient with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment in Siriraj Hospital.
Visavachaipan N; Ong-Ajyooth L; Chanchairujuira T; Parichatikanond P; Choensuchon B
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S139-46. PubMed ID: 20364568
[TBL] [Abstract][Full Text] [Related]
40. [Purpura in a young woman with hyperthyroidism].
Giraud-Kerleroux L; Bernigaud C; Droumaguet C; Thai LH; Marciano-Fellous L; Thomas L; Charpentier C; Helbert-Davidson S; Fardet L; Hüe S; Ingen-Housz-Oro S
Rev Med Interne; 2021 Jul; 42(7):509-512. PubMed ID: 33846035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
